Bevacizumab, irinotecan, and temozolomide with re-irradiation in adult recurrent medulloblastoma: A first case report

被引：1
|
作者：
Yamauchi, Takahiro [1 ,4 ]
Kitai, Ryuhei [1 ,2 ]
Arai, Hiroshi [3 ]
Kidoguchi, Masamune [3 ]
Isozaki, Makoto [1 ]
Kodera, Toshiaki [1 ]
Kikuta, Ken-ichiro [1 ]
机构：
[1] Univ Fukui, Div Med, Dept Neurosurg, Fac Med Sci, 23-3 Matsuokashimoaizuki,Eiheiji Cho, Fukui 9101193, Japan
[2] Kaga Med Ctr, Dept Neurosurg, Kaga, Ishikawa, Japan
[3] Municipal Tsuruga Hosp, Dept Neurosurg, Tsuruga, Fukui, Japan
[4] Univ Fukui, Dept Hematol & Oncol, Fac Med Sci, Fukui, Japan
来源：
INTERDISCIPLINARY NEUROSURGERY-ADVANCED TECHNIQUES AND CASE MANAGEMENT | 2021年 / 25卷
关键词：
Adult recurrent medulloblastoma; Bevacizumab; Irinotecan; Temozolomide; PROGNOSTIC-FACTORS; PHASE-II; CHILDREN; CHEMOTHERAPY; SURVIVAL; THERAPY; TUMOR;
D O I：
10.1016/j.inat.2021.101249
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
Medulloblastoma in adults is very rare, and there is no effective therapy for its initial appearance or recurrence. We present a case of a 40-year-old male with recurrent medulloblastoma despite initial radiochemotherapy. He received re-irradiation and 6 courses of bevacizumab, irinotecan, and temozolomide after which he remained stable for 6 months. This regimen may be promising for recurrent medulloblastoma in adults.
引用
收藏
页数：4
相关论文
共 50 条
  • [21] Bevacizumab and re-irradiation for recurrent high grade gliomas: does sequence matter?
    Joshua D. Palmer
    Deepak Bhamidipati
    Andrew Song
    Harriet B. Eldredge-Hindy
    Joshua Siglin
    Tu D. Dan
    Colin E. Champ
    Isabella Zhang
    Voichita Bar-Ad
    Lyndon Kim
    Jon Glass
    James J. Evans
    David W. Andrews
    Maria Werner-Wasik
    Wenyin Shi
    Journal of Neuro-Oncology, 2018, 140 : 623 - 628
  • [22] Response to bevacizumab, irinotecan, and temozolomide in children with relapsed medulloblastoma: a multi-institutional experience
    Aguilera, Dolly
    Mazewski, Claire
    Fangusaro, Jason
    MacDonald, Tobey J.
    McNall-Knapp, Rene Y.
    Hayes, Laura L.
    Kim, Sungjin
    Castellino, Robert C.
    CHILDS NERVOUS SYSTEM, 2013, 29 (04) : 589 - 596
  • [23] Response to bevacizumab, irinotecan, and temozolomide in children with relapsed medulloblastoma: a multi-institutional experience
    Dolly Aguilera
    Claire Mazewski
    Jason Fangusaro
    Tobey J. MacDonald
    Rene Y. McNall-Knapp
    Laura L. Hayes
    Sungjin Kim
    Robert C. Castellino
    Child's Nervous System, 2013, 29 : 589 - 596
  • [24] Re-irradiation for children with recurrent medulloblastoma in Toronto, Canada: a 20-year experience
    Tsang, Derek S.
    Sarhan, Nasim
    Ramaswamy, Vijay
    Nobre, Liana
    Yee, Ryan
    Taylor, Michael D.
    Hawkins, Cynthia
    Bartels, Ute
    Huang, Annie
    Tabori, Uri
    Hodgson, David C.
    Bouffet, Eric
    Laperriere, Normand
    JOURNAL OF NEURO-ONCOLOGY, 2019, 145 (01) : 107 - 114
  • [25] Outcomes of salvage fractionated re-irradiation combined with bevacizumab for recurrent high-grade gliomas that progressed after bevacizumab treatment
    Yonezawa, Hajime
    Ohno, Makoto
    Igaki, Hiroshi
    Miyakita, Yasuji
    Takahashi, Masamichi
    Tamura, Yukie
    Shima, Satoshi
    Matsushita, Yuko
    Ichimura, Koichi
    Narita, Yoshitaka
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2021, 51 (07) : 1028 - 1035
  • [26] Salvage re-irradiation for recurrent high-grade glioma and comparison to bevacizumab alone
    Arvold, Nils D.
    Shi, Diana D.
    Aizer, Ayal A.
    Norden, Andrew D.
    Reardon, David A.
    Lee, Eudocia Q.
    Nayak, Lakshmi
    Dunn, Ian F.
    Golby, Alexandra J.
    Johnson, Mark D.
    Claus, Elizabeth B.
    Chiocca, E. Antonio
    Ligon, Keith L.
    Wen, Patrick Y.
    Alexander, Brian M.
    JOURNAL OF NEURO-ONCOLOGY, 2017, 135 (03) : 581 - 591
  • [27] Salvage re-irradiation for recurrent high-grade glioma and comparison to bevacizumab alone
    Nils D. Arvold
    Diana D. Shi
    Ayal A. Aizer
    Andrew D. Norden
    David A. Reardon
    Eudocia Q. Lee
    Lakshmi Nayak
    Ian F. Dunn
    Alexandra J. Golby
    Mark D. Johnson
    Elizabeth B. Claus
    E. Antonio Chiocca
    Keith L. Ligon
    Patrick Y. Wen
    Brian M. Alexander
    Journal of Neuro-Oncology, 2017, 135 : 581 - 591
  • [28] Re-irradiation for recurrent glioblastoma multiforme: a critical comparison of different concepts
    Baehr, A.
    Trog, D.
    Oertel, M.
    Welsch, S.
    Kroeger, K.
    Grauer, O.
    Haverkamp, U.
    Eich, H. T.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2020, 196 (05) : 457 - 464
  • [29] A phase I study of irinotecan and temozolomide with bevacizumab in children with recurrent/refractory central nervous system tumors
    Metts, Jonathan
    Harrington, Brittany
    Salman, Emad
    Bradfield, Scott M.
    Flanary, Jennifer
    Mosha, Maua
    Amankwah, Ernest
    Stapleton, Stacie
    CHILDS NERVOUS SYSTEM, 2022, 38 (05) : 919 - 928
  • [30] Antineoplastics/folinic acidThromboembolism (first report with bevacizumab and irinotecan): case report
    Reactions Weekly, 2007, 1133 (1) : 5 - 5
12345